Chart 3. Treatment of multidrug-resistant and extensively drug-resistant tuberculosis.
Resistance | Phase | Druga,b | Body weight, kg | Dose | Treatment duration, months |
R + H (± S) | Intensive | Cm3 | 30 | 15-20 mg/kg/day | 8 |
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 1,000 mg/day | ||||
> 70 | 1,000 mg/day | ||||
E | 30 | 15-25 mg/kg/day | |||
31-45 | 800 mg/day | ||||
46-55 | 1,200 mg/day | ||||
56-70 | 1,200 mg/day | ||||
> 70 | 1,200 mg/day | ||||
Z | 30 | 20-30 mg/kg/day | |||
31-45 | 1,000 mg/day | ||||
46-55 | 1,500 mg/day | ||||
56-70 | 1,500 mg/day | ||||
> 70 | 2,000 mg/day | ||||
Lfx | 30 | 10-15 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 1,000 mg/day | ||||
> 70 | 1,000 mg/day | ||||
Trd | 30 | 10-20 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 500 mg/day | ||||
56-70 | 750 mg/day | ||||
> 70 | 750 mg/day | ||||
Maintenance | E | 30 | 15-25 mg/kg/day | 10 | |
31-45 | 800 mg/day | ||||
46-55 | 1,200 mg/day | ||||
56-70 | 1,200 mg/day | ||||
> 70 | 1,200 mg/day | ||||
Lfx | 30 | 10-15 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 1,000 mg/day | ||||
> 70 | 1,000 mg/day | ||||
Trd | 30 | 10-20 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 500 mg/day | ||||
56-70 | 750 mg/day | ||||
> 70 | 750 mg/day | ||||
R + H + E (± S) or R + H + E + Z (± S) | Intensive | Cm3 | 30 | 15-20 mg/kg/day | 8 |
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 1,000 mg/day | ||||
> 70 | 1,000 mg/day | ||||
Et | 30 | 15-20 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 750 mg/day | ||||
> 70 | 750 mg/day | ||||
Z | 30 | 20-30 mg/kg/day | |||
31-45 | 1,000 mg/day | ||||
46-55 | 1,500 mg/day | ||||
56-70 | 1,500 mg/day | ||||
> 70 | 2,000 mg/day | ||||
Lfx | 30 | 10-15 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 1,000 mg/day | ||||
> 70 | 1,000 mg/day | ||||
Trd | 30 | 10-20 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 500 mg/day | ||||
56-70 | 750 mg/day | ||||
> 70 | 750 mg/day | ||||
Maintenance | Et | 30 | 15-20 mg/kg/day | 10 | |
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 750 mg/day | ||||
> 70 | 750 mg/day | ||||
Lfx | 30 | 10-15 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 1,000 mg/day | ||||
> 70 | 1,000 mg/day | ||||
Trd | 30 | 10-20 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 500 mg/day | ||||
56-70 | 750 mg/day | ||||
> 70 | 750 mg/day | ||||
R + H + Z (± S) | Intensive | Cm3 | 30 | 15-20 mg/kg/day | 8 |
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 1,000 mg/day | ||||
> 70 | 1,000 mg/day | ||||
E | 30 | 15-25 mg/kg/day | |||
31-45 | 800 mg/day | ||||
46-55 | 1,200 mg/day | ||||
56-70 | 1,200 mg/day | ||||
> 70 | 1,200 mg/day | ||||
Z | 30 | 20-30 mg/kg/day | |||
31-45 | 1,000 mg/day | ||||
46-55 | 1,500 mg/day | ||||
56-70 | 1,500 mg/day | ||||
> 70 | 2,000 mg/day | ||||
Lfx | 30 | 10-15 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 1,000 mg/day | ||||
> 70 | 1,000 mg/day | ||||
Et | 30 | 15-20 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 750 mg/day | ||||
> 70 | 750 mg/day | ||||
Trd | 30 | 10-20 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 500 mg/day | ||||
56-70 | 750 mg/day | ||||
> 70 | 750 mg/day | ||||
Maintenance | E | 30 | 15-25 mg/kg/day | 10 | |
31-45 | 800 mg/day | ||||
46-55 | 1,200 mg/day | ||||
56-70 | 1,200 mg/day | ||||
> 70 | 1,200 mg/day | ||||
Lfx | 30 | 10-15 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 1,000 mg/day | ||||
> 70 | 1,000 mg/day | ||||
Et | 30 | 15-20 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 750 mg/day | ||||
56-70 | 750 mg/day | ||||
> 70 | 750 mg/day | ||||
Trd | 30 | 10-20 mg/kg/day | |||
31-45 | 500 mg/day | ||||
46-55 | 500 mg/day | ||||
56-70 | 750 mg/day | ||||
> 70 | 750 mg/day |
R: rifampin; H: isoniazid; S: streptomycin; Cm: capreomycin; E: ethambutol; Z: pyrazinamide; Lfx: levofloxacin; Trd: terizidone; and Et: ethionamide. aThe subscript number after a drug abbreviation indicates the number of days per week that the drug will be used; if there is no subscript number, treatment with that drug is daily. bIn patients who have already used capreomycin, use amikacin as an alternative. In patients who do not have resistance to streptomycin as determined by drug susceptibility testing and who have not used amikacin, amikacin can also be considered for use. Doses of amikacin and streptomycin: up to 30 kg, 15-20 mg/kg/day; from 31 to 45 kg, 500 mg/day; from 46 to 55 kg, 750 mg/day; ≥ 56 kg, 1,000 mg/day.